IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 171 filers reported holding IVERIC BIO INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,614,847 | +2908.0% | 193,565 | +1537.1% | 0.02% | +2200.0% |
| Q4 2022 | $253,152 | -75.5% | 11,824 | -79.5% | 0.00% | -80.0% |
| Q3 2022 | $1,034,000 | +137.7% | 57,663 | +27.6% | 0.01% | +150.0% |
| Q2 2022 | $435,000 | -42.4% | 45,201 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $755,000 | -45.8% | 45,155 | -47.3% | 0.00% | -50.0% |
| Q3 2021 | $1,392,000 | +145.1% | 85,684 | -4.8% | 0.00% | +100.0% |
| Q2 2021 | $568,000 | -3.6% | 90,007 | -5.5% | 0.00% | -33.3% |
| Q1 2021 | $589,000 | +47.6% | 95,237 | +64.9% | 0.00% | 0.0% |
| Q4 2020 | $399,000 | +118.0% | 57,756 | +60.9% | 0.00% | 0.0% |
| Q2 2020 | $183,000 | -37.3% | 35,892 | -57.7% | 0.00% | -57.1% |
| Q1 2020 | $292,000 | +1.4% | 84,855 | +153.0% | 0.01% | +250.0% |
| Q4 2019 | $288,000 | +1700.0% | 33,545 | +167.1% | 0.00% | – |
| Q2 2019 | $16,000 | – | 12,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |